Posts Tagged: Stem cell
Sather Gate at the University of California at Berkeley. (Photo: David A. Litman, via Shutterstock)
The University of California has identified its 10 best research stories of 2021, and right at the top is an article deeply involving the state’s $12 billion stem cell agency. The catch is that the stem cell agency was not even mentioned. That despite the fact that 13 persons with significant links to the University of California, including a UC regent, sit on the board that oversees the agency.
A research scientist examines a capsule with a DNA double helix. (Photo: Dan Race, via Shutterstock)
One year ago this month, a $5.5 billion wave washed over California’s ambitious stem cell agency and left it refreshed and renewed for another decade or so of searching for “miraculous” treatments for a host of deadly, incurable afflictions. It is now on a pace to hand out $38,000 an hour, 24 hours a day, seven days a week. That would amount to $519 million in awards between this time last year and the end of the agency’s current fiscal year in June.
Two of the members of the CIRM governing board, Chair Jon Thomas and Vice Chair Art Torres, during an earlier meeting.(Photo: CIRM)
Directors of the $12 billion California stem cell agency have moved to weaken conflict of interest provisions affecting its governing board — eliminating “leave-the-room” requirements that are used by most private nonprofits to assure the integrity of their operations.
Close up of laboratory microscope with DNA gel background image. (Photo: 18percentgrey, via Shutterstock)
Directors of the California stem cell agency last week handed out $2 million a minute to nearly 20 organizations during an online meeting that spread the largess from Sacramento in the north to San Diego in the south.
The Lorry I. Loke Stem Cell Research Building at Stanford University. (Photo: CIRM)
California’s taxpayer-financed stem cell agency will give away $98 million later this week, but the agency’s full, 35-member board is not going to have much to do with making decisions about who gets what. That’s because 17 members of the governing board are barred from voting on applications for any of its research awards, which will ultimately total roughly $5 billion over the next decade or so.
An illustration of DNA being injected into a stem cell. (Image: Spectral-Design, via Shutterstock)
The folks in Orange Cove in California’s agriculturally rich Central Valley care about the cost of health care. It is part of their struggle each day as they try to live on $27,000 a year, the lowest median household income of any town in the Golden State. Over in Oakland at the headquarters of the $12 billion state stem cell agency, the folks there are also worried about the cost of health care, particularly cell and gene therapies that may well cost upwards of $2 million.
Berkeley City College, which received a portion of $51 million in state stem cell research grants. (Photo: berkeleyside.org)
The California stem cell agency has awarded $51 million to help train students in the art of research at the Golden State’s community colleges and universities. All 15 applicants for awards that ran as high as $3.6 million each were approved, including Berkeley City College, which was initially rejected by anonymous reviewers who met privately prior to the ratification of their decisions by the agency’s directors.
A scientist at work in a biomedical laboratory. (Photo: Tom Robertson, via Shutterstock)
The California stem cell agency says it is doing “everything” it can to move forward on a gene therapy that has saved the lives of more than 50 persons but which has been pushed aside by the company that has exclusive rights to it. The issue has raised questions about the ethics of withholding care from babies and children suffering from a fatal disease.
A pipette and receptacles used in stem cell research. (Photo: CI Photos)
The talk at the California stem cell agency this week was of ”boiling the ocean,” the meaning of “unlikely” and “DEI.” All of which involves how $5.5 billion in taxpayer dollars will be used over the next decade or so.
A stem cell researcher at UC Davis. (Photo: AJ Cheline, UC Davis, via The Stem Cellar)
Backed by $17 million in cash from California’s stem cell agency, researchers at UC Davis this month are launching “the world’s first clinical trial using stem cells to treat spina bifida before the child is born.”